Alpa Laboratories Limited (NSE:ALPA)

Market Cap	1.45B -37.3%
Revenue (ttm)	1.14B +18.9%
Net Income	116.09M -53.9%
EPS	5.52 -53.8%
Shares Out	21.04M
PE Ratio	12.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,810
Average Volume	50,883
Open	68.55
Previous Close	69.57
Day's Range	67.10 - 70.69
52-Week Range	46.10 - 120.50
Beta	0.76
RSI	59.47
Earnings Date	May 26, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 453
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In fiscal year 2025, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.